NOVO NORDISK PHARMACEUTICALS A/S: Financial statements 2017
CVR: 24257924
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NOVO NORDISK PHARMACEUTICALS A/S (CVR 24257924) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -2,285,000 compared with DKK 1,694,000 the year before. Equity in the 2017 report amounted to DKK 13,831,000. The solvency ratio was 99.8%.
- Profit/Loss
- DKK -2,285,000
- Equity
- DKK 13,831,000
- Total Assets
- DKK 13,859,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -2.3M | 13.8M | - |
| 2016 | - | - | 1.7M | 16.1M | - |
| 2015 | - | - | 1.9M | 14.4M | - |
| 2014 | - | - | 3.2M | 12.5M | - |
Official annual report
Keep an eye on NOVO NORDISK PHARMACEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 1, 2017, Lene Moth Bang has joined the board of directors of NOVO NORDISK PHARMACEUTICALS A/S.
As of June 1, 2017, Lars Fruergaard Jørgensen has left the board of directors of NOVO NORDISK PHARMACEUTICALS A/S.
NOVO NORDISK PHARMACEUTICALS A/S has published its annual report for 2016. The net result was DKK 1,694,000.
About NOVO NORDISK PHARMACEUTICALS A/S
NOVO NORDISK PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named NOVO FARMAKA A/S. The management consists of Anders Rytter Mikkelsen. The board consists of Naja Eilers Barrisøe (chair), Linette Tangsgaard Nielsen and Thomas Rask Nielsen. The company is owned by NOVO NORDISK A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -53,000 and a net result of DKK 2,074,000 compared with DKK 6,918,000 the year before. Equity in the 2025 report amounted to DKK 12,325,000.
